The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Polar Capital Funds PLC & Others
NEPHROPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Polar Capital Funds PLC, acting through three healthcare-focused funds (Healthcare Opportunities Fund, Emerging Markets Healthcare Fund, and Healthcare Discovery Fund), has crossed the 5% shareholding threshold in Nephrocare Health Services Ltd. The acquirer purchased 214,331 equity shares (0.214% of total equity) through open market transactions on 19 December 2025. Prior to this acquisition, Polar Capital held 4.843% (4,859,925 shares); after the purchase, its combined holding stands at 5.057% (5,074,256 shares). The acquirer is not part of the promoter or promoter group. This disclosure was filed under SEBI SAST Regulation 29(1) because the 5% threshold was breached. The total equity share capital of the company remains unchanged at 100,340,717 shares.
For retail shareholders, this signals continued institutional confidence from a global healthcare-focused fund, which may provide some support to the stock. However, with FII holding just above the 5% disclosure mark, further buying could trigger additional regulatory filings, and any future selling may also need disclosure once crossings above 5% occur.